奧思集團(01161.HK)盈警:預計中期純利同比減少不少於4000萬港元
格隆匯5月17日丨奧思集團(01161.HK)公佈,截至2024年3月31日止六個月,集團預計所錄得的股東應占純利將減少不少於4000萬港元,而截至2023年3月31日止六個月期間則錄得約5710萬港元。
錄得減少主要由於:(1)高績效員工挽留措施導致員工成本增加;(2)為提升集團品牌形象,投資於高知名度及高影響力之廣吿活動導致營銷開支增加;及(3)確認非現金商譽減值約1140萬港元。為提升集團之盈利能力,集團將專注於在香港零售銷售來自日本的優質護膚及美容產品HABA產品,及由於表現未如理想,故將不會延長HABA產品於中國內地之分銷權。集團謹此強調,上述商譽減值將不會對集團之營運造成任何現金流影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.